Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22480758

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2012 May 12
First author
Engert A

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 May 12;379(9828):1790
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2012 May 12;379(9828):1767-8. doi: 10.1016/S0140-6736(12)60153-6.
    note
    Source null
    related pmid
    22480757
    relationship
    Comment in

Authors and identifiers

  1. name
    Engert A
    type
    Author
  2. name
    Haverkamp H
    type
    Author
  3. name
    Kobe C
    type
    Author
  4. name
    Markova J
    type
    Author
  5. name
    Renner C
    type
    Author
  6. name
    Ho A
    type
    Author
  7. name
    Zijlstra J
    type
    Author
  8. name
    Král Z
    type
    Author
  9. name
    Fuchs M
    type
    Author
  10. name
    Hallek M
    type
    Author
  11. name
    Kanz L
    type
    Author
  12. name
    Döhner H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Engert A
    type
    Author
  2. name
    Haverkamp H
    type
    Author
  3. name
    Kobe C
    type
    Author
  4. name
    Markova J
    type
    Author
  5. name
    Renner C
    type
    Author
  6. name
    Ho A
    type
    Author
  7. name
    Zijlstra J
    type
    Author
  8. name
    Král Z
    type
    Author
  9. name
    Fuchs M
    type
    Author
  10. name
    Hallek M
    type
    Author
  11. name
    Kanz L
    type
    Author
  12. name
    Döhner H
    type
    Author
bibliography ids
  1. nci-bib-67492b3983931a922823f8fc
book metadata
content sha256
c148924ed563e099bfc33387fc9f766a71684a22d3c575459407db9f6a636ea0
document type
citation
dois
  1. 10.1016/S0140-6736(11)61940-5
electronic publication date
display
2012 Apr 4
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22480758
immutable id
pubmed:22480758@c148924ed563e099bfc33387fc9f766a71684a22d3c575459407db9f6a636ea0
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9828
name
Lancet (London, England)
nlm unique id
2985213R
pages
1791-9
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2012 May 12;379(9828):1790
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2012 May 12;379(9828):1767-8. doi: 10.1016/S0140-6736(12)60153-6.
    note
    Source null
    related pmid
    22480757
    relationship
    Comment in
outcomes validated
false
pmid
22480758
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
22caf0100d59106e1281b7c9ce9b0778af328bf18c376d1711c096b3451bd564
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 May 12
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22480758/
title
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Preserved source evidence · Not medical advice